Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.6100 (-5.3%) ($28.1100 - $30.0000) on Thu. Oct. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 38 | Latest Price | $28.6100(-5.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.48% in a week (0% probabilities). VXX(-13%) VIXM(-12%) IFRA(-6%) TLT(-5%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0 () | Intraday Trend | -4.6% | | | |
|
1 - 5 Day Possible Target | $22.4(-21.71%) | Resistance Level | $31.44 | 5 Day Moving Average | $30.04(-4.76%) | 10 Day Moving Average | $30.79(-7.08%) | 20 Day Moving Average | $31.44(-9%) | To recent high | -25.5% | To recent low | 3.5% | Market Cap | $1.777b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |